Administration Assistant
January 5, 2024
Business Update – March 2024
February 18, 2024
The Life Science sector anticipates rapid technological advancements in 2024, heightened regulatory scrutiny, and evolving challenges. Insurers are adapting to address these trends and provide specialised coverage.
Technological Advances
The sector’s rapid technological progress in areas such as gene editing and artificial intelligence in drug discovery is prompting insurers to develop specialised policies. These are designed to ensure coverage for potential liabilities arising from cutting-edge technologies.
Regulatory Scrutiny
Growing regulatory complexity requires insurers to collaborate with life science companies to create policies that cover compliance risks, helping companies navigate evolving regulatory standards.
Bio-manufacturing and Supply Chain Risks
The shift to advanced bio-manufacturing processes necessitates insurance coverage for supply chain vulnerabilities, contamination events, and business interruptions, thereby aligning with the industry’s evolving needs.
Cybersecurity Concerns
Increasing reliance on digital technologies highlights the need for cybersecurity coverage in the sector. Customised insurance products are available to protect life science companies from data breaches, intellectual property theft, and cyber disruptions.
Pandemic Preparedness
The industry prioritises pandemic preparedness plans post-COVID-19. Insurers work with industry to develop comprehensive coverage for business interruptions, supply chain disruptions, and research delays during global health crises.
Insurers will continue to play a pivotal role in 2024 and beyond in supporting the growth and resilience of the life science industry. Keystone can offer tailored solutions that address the technological, regulatory, and global challenges faced. We have the skills and know-how to review your client’s requirements, so please reach out to discuss a solution and ways we can provide a partnership with the insured in the long term.
